BIO IMAGING TECHNOLOGIES INC
10QSB, EX-27, 2000-08-14
MEDICAL LABORATORIES
Previous: BIO IMAGING TECHNOLOGIES INC, 10QSB, 2000-08-14
Next: PIMCO ADVISORS L P /, 13F-HR, 2000-08-14



<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
UNAUDITED INTERIM FINANCIAL  STATEMENTS INCLUDED IN THE REGISTRANT'S FORM 10-QSB
FOR THE  PERIOD  ENDED  JUNE  30,  2000 AND IS  QUALIFIED  IN  ITS  ENTIRETY  BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                         0000822418
<NAME>                        Bio-Imaging Technologies, Inc.
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              SEP-30-2000
<PERIOD-START>                                 OCT-01-1999
<PERIOD-END>                                   JUN-30-2000
<EXCHANGE-RATE>                                1
<CASH>                                         134,464
<SECURITIES>                                   0
<RECEIVABLES>                                  2,273,906
<ALLOWANCES>                                   65,000
<INVENTORY>                                    0
<CURRENT-ASSETS>                               2,561,436
<PP&E>                                         3,165,541
<DEPRECIATION>                                 1,782,580
<TOTAL-ASSETS>                                 4,172,143
<CURRENT-LIABILITIES>                          2,685,696
<BONDS>                                        207,655
                          0
                                    104
<COMMON>                                       1,944
<OTHER-SE>                                     1,276,744
<TOTAL-LIABILITY-AND-EQUITY>                   4,172,143
<SALES>                                        0
<TOTAL-REVENUES>                               4,105,911
<CGS>                                          0
<TOTAL-COSTS>                                  2,705,862
<OTHER-EXPENSES>                               2,102,586
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             54,831
<INCOME-PRETAX>                                (757,368)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (757,368)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (757,368)
<EPS-BASIC>                                    (0.10)
<EPS-DILUTED>                                  (0.10)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission